CYSTADROPS gtt opht 3.8 mg/ml fl 5 ml

7680673800010 CH-67380 S01XA21 07.99.0.
CYSTADROPS gtt opht 3.8 mg/ml fl 5 ml
CYSTADROPS gtt opht 3.8 mg/ml fl 5 ml
CYSTADROPS gtt opht 3.8 mg/ml fl 5 ml
1 / 3
google

Details

Product number
6738001
CPT
-
Packaging group
5
Unit
ml
Composition
mercaptaminum 3.8 mg ut mercaptamini hydrochloridum, carmellosum natricum, benzalkonii chloridum 0.1 mg, dinatrii edetas, acidum citricum monohydricum, natrii hydroxidum, acidum hydrochloridum, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 1 ml.

Articles (1)

Cystadrops 3.8 mg/ml, Augentropfen
Augentropfen
5
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
08/10/2025
Patient information leaflet
Français
08/10/2025
Patient information leaflet
Italien
08/10/2025
Professional SmPC
Allemand
08/10/2025
Professional SmPC
Français
08/10/2025
Professional SmPC
Italien
08/10/2025

Detailed composition

Substance Quantity Type Category
(N/A)
3.8 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
0.1 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

RECORDATI AG

4057 Basel

Authorization information

Swissmedic authorization number
67380
Drug name
Cystadrops, Augentropfen
Galenic form
AUGT
ATC Code
S01XA21
Authorization status
Z
Dispensation category
B
First authorization
24/09/2020
Authorization expiration date
31/12/9999
IT number
07.99.0.
Domain
Human medicine
Field of application
Cystinablagerungen in der Hornhaut

Packaging details

Description (FR)
CYSTADROPS gtt opht 3.8 mg/ml fl 5 ml
Description (DE)
CYSTADROPS Gtt Opht 3.8 mg/ml Fl 5 ml
Market launch
24/09/2020
Narcotic (BTM)
No